With all due respect @Alee26 one needs to look at how the BOD of any company uses this said cash burn. Now cash burn can be due to just running a company eg salaries leases loans overseas trips etc and use zero on moving forward to the detriment of SHers. Naturally I'm not saying IHL won't use part of COH to run the company but the BOD have so many pathways and benchmarks set, from new patents, regletory approvals, production for administer, clinical phase 2/3trials through to clinic outlets with approved trained therapists/medical personnel, all of which will advance their position closer to commercialization on a number of fronts and closer to an income stream. These BOD are working for their SHers but most importantly is if the above plays out there is going to a lot of people with improved lifestyle due to these compounds. Mental health, depression, insomnia and inflammation are hidious. I suffer from some of the above and it's terrible. Bring on the cash burn the BOD need so one day we can make sufferers lives comfortable again and smile. Good luck Alee26
IHL Price at posting:
10.8¢ Sentiment: Buy Disclosure: Held
